Skip to main content
Clinical Trials/NL-OMON52756
NL-OMON52756
Recruiting
Not Applicable

A prospective, explorative cohort study to assess the value of an ex vivo radiosensitivity assay as a BIOmarker of treatment Response in Oropharyngeal Cancer (BIO-ROC). - The BIO-ROC study

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
oropharyngeal cancer
Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Enrollment
200
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- Clinical diagnosis of squamous cell carcinoma of the oropharynx, with or
  • without histological confirmation
  • \- In case of already histology\-confirmed oropharyngeal cancer \- primary tumor
  • accessible for re\-sampling without general anaesthesia
  • \- Eligible for curative treatment with radiotherapy with or without the
  • addition of systemic agents
  • \- Written informed consent obtained
  • \- Age \>\= 18 years

Exclusion Criteria

  • \- Patients with histology\-confirmed oropharyngeal cancer, only accessible for
  • re\-sampling only under general anaesthesia
  • \- Patients currently under treatment for other malignant disease (unless basal
  • cell carcinoma of the skin)
  • \- Previous radiotherapy in the head and neck area (with overlapping RT area)
  • \- Recurrent oropharyngeal cancer

Outcomes

Primary Outcomes

Not specified

Similar Trials